title: Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease.
abstract: BACKGROUND
  Inhibition of gamma-secretase presents a direct target for lowering Aβ production in the brain as a therapy for Alzheimer's disease (AD). However, gamma-secretase is known to process multiple substrates in addition to amyloid precursor protein (APP), most notably Notch, which has limited clinical development of inhibitors targeting this enzyme. It has been postulated that APP substrate selective inhibitors of gamma-secretase would be preferable to non-selective inhibitors from a safety perspective for AD therapy.
  
  
  METHODS
  In vitro assays monitoring inhibitor potencies at APP γ-site cleavage (equivalent to Aβ40), and Notch ε-site cleavage, in conjunction with a single cell assay to simultaneously monitor selectivity for inhibition of Aβ production vs. Notch signaling were developed to discover APP selective gamma-secretase inhibitors. In vivo efficacy for acute reduction of brain Aβ was determined in the PDAPP transgene model of AD, as well as in wild-type FVB strain mice. In vivo selectivity was determined following seven days x twice per day (b.i.d.) treatment with 15 mg/kg/dose to 1,000 mg/kg/dose ELN475516, and monitoring brain Aβ reduction vs. Notch signaling endpoints in periphery.
  
  
  RESULTS
  The APP selective gamma-secretase inhibitors ELN318463 and ELN475516 reported here behave as classic gamma-secretase inhibitors, demonstrate 75- to 120-fold selectivity for inhibiting Aβ production compared with Notch signaling in cells, and displace an active site directed inhibitor at very high concentrations only in the presence of substrate. ELN318463 demonstrated discordant efficacy for reduction of brain Aβ in the PDAPP compared with wild-type FVB, not observed with ELN475516. Improved in vivo safety of ELN475516 was demonstrated in the 7d repeat dose study in wild-type mice, where a 33% reduction of brain Aβ was observed in mice terminated three hours post last dose at the lowest dose of inhibitor tested. No overt in-life or post-mortem indications of systemic toxicity, nor RNA and histological end-points indicative of toxicity attributable to inhibition of Notch signaling were observed at any dose tested.
  
  
  CONCLUSIONS
  The discordant in vivo activity of ELN318463 suggests that the potency of gamma-secretase inhibitors in AD transgenic mice should be corroborated in wild-type mice. The discovery of ELN475516 demonstrates that it is possible to develop APP selective gamma-secretase inhibitors with potential for treatment for AD.
authors.affiliation: Elan Pharmaceuticals, Inc, 180 Oyster Point Blvd, S, San Francisco, CA 94080, USA. guriq.basi@neotopebio.com.
authors.forename: Guriqbal S
authors.initials: GS
authors.lastname: Basi
authors.forename: Susanna
authors.initials: S
authors.lastname: Hemphill
authors.forename: Elizabeth F
authors.initials: EF
authors.lastname: Brigham
authors.forename: Anna
authors.initials: A
authors.lastname: Liao
authors.forename: Danielle L
authors.initials: DL
authors.lastname: Aubele
authors.forename: Jeanne
authors.initials: J
authors.lastname: Baker
authors.forename: Robin
authors.initials: R
authors.lastname: Barbour
authors.forename: Michael
authors.initials: M
authors.lastname: Bova
authors.forename: Xiao-Hua
authors.initials: XH
authors.lastname: Chen
authors.forename: Michael S
authors.initials: MS
authors.lastname: Dappen
authors.forename: Tovah
authors.initials: T
authors.lastname: Eichenbaum
authors.forename: Erich
authors.initials: E
authors.lastname: Goldbach
authors.forename: Jon
authors.initials: J
authors.lastname: Hawkinson
authors.forename: Rose
authors.initials: R
authors.lastname: Lawler-Herbold
authors.forename: Kang
authors.initials: K
authors.lastname: Hu
authors.forename: Terence
authors.initials: T
authors.lastname: Hui
authors.forename: Jacek J
authors.initials: JJ
authors.lastname: Jagodzinski
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Keim
authors.forename: Dora
authors.initials: D
authors.lastname: Kholodenko
authors.forename: Lee H
authors.initials: LH
authors.lastname: Latimer
authors.forename: Mike
authors.initials: M
authors.lastname: Lee
authors.forename: Jennifer
authors.initials: J
authors.lastname: Marugg
authors.forename: Matthew N
authors.initials: MN
authors.lastname: Mattson
authors.forename: Scott
authors.initials: S
authors.lastname: McCauley
authors.forename: James L
authors.initials: JL
authors.lastname: Miller
authors.forename: Ruth
authors.initials: R
authors.lastname: Motter
authors.forename: Linda
authors.initials: L
authors.lastname: Mutter
authors.forename: Martin L
authors.initials: ML
authors.lastname: Neitzel
authors.forename: Huifang
authors.initials: H
authors.lastname: Ni
authors.forename: Lan
authors.initials: L
authors.lastname: Nguyen
authors.forename: Kevin
authors.initials: K
authors.lastname: Quinn
authors.forename: Lany
authors.initials: L
authors.lastname: Ruslim
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Semko
authors.forename: Paul
authors.initials: P
authors.lastname: Shapiro
authors.forename: Jenifer
authors.initials: J
authors.lastname: Smith
authors.forename: Ferdie
authors.initials: F
authors.lastname: Soriano
authors.forename: Balazs
authors.initials: B
authors.lastname: Szoke
authors.forename: Kevin
authors.initials: K
authors.lastname: Tanaka
authors.forename: Pearl
authors.initials: P
authors.lastname: Tang
authors.forename: John A
authors.initials: JA
authors.lastname: Tucker
authors.forename: Xiacong Michael
authors.initials: XM
authors.lastname: Ye
authors.forename: Mei
authors.initials: M
authors.lastname: Yu
authors.forename: Jing
authors.initials: J
authors.lastname: Wu
authors.forename: Ying-Zi
authors.initials: YZ
authors.lastname: Xu
authors.forename: Albert W
authors.initials: AW
authors.lastname: Garofalo
authors.forename: John Michael
authors.initials: JM
authors.lastname: Sauer
authors.forename: Andrei W
authors.initials: AW
authors.lastname: Konradi
authors.forename: Daniel
authors.initials: D
authors.lastname: Ness
authors.forename: George
authors.initials: G
authors.lastname: Shopp
authors.forename: Michael A
authors.initials: MA
authors.lastname: Pleiss
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Freedman
authors.forename: Dale
authors.initials: D
authors.lastname: Schenk